Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size

Journal of Experimental Medicine

Volumn 201, Issue 11, 2005, Pages 1781-1791

  Stier, Sebastian ^a,b,c   Ko, Yon ^c   Forkert, Randolf ^a,b,c   Lutz, Christoph ^a,b,c   Neuhaus, Thomas ^c   Grünewald, Elisabeth ^c   Cheng, Tao ^a,b   Dombkowski, David ^a,b   Calvi, Laura M ^d   Rittling, Susan R ^e   Scadden, David T ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d UNIVERSITY OF ROCHESTER   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; GLYCOPROTEIN; JAGGED1; NERVE CELL ADHESION MOLECULE; OSTEOPONTIN; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL FUNCTION; CELL SIZE; CELL STIMULATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STROMA CELL;

ANGIOPOIETIN-1; ANIMALS; APOPTOSIS; BONE MARROW; CALCIUM-BINDING PROTEINS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; OSTEOBLASTS; OSTEOPONTIN; PARATHYROID HORMONE; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION;

EID: 21244472780     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041992     Document Type: Article

References (50)

1. Kiger, A.A., D.L. Jones, C. Schulz, M.B. Rogers, and M.T. Fuller. 2001. Stem cell self-renewal specified by JAK-STAT activation in response to a support cell cue. Science. 294:2542-2545.
2. Xie, T., and A.C. Spradling. 2000. A niche maintaining germ line stem cells in the Drosophila ovary. Science. 290:328-330.
3. Zhang, J., C. Niu, L. Ye, H. Huang, X. He, W.G. Tong, J. Ross, J. Haug, T. Johnson, J.Q. Feng, et al. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 425:836-841.
4. Calvi, L.M., G.B. Adams, K.W. Weibrecht, J.M. Weber, D.P. Olson, M.C. Knight, R.P. Martin, E. Schipani, P. Divieti, F.R. Bringhurst, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 425:841-846.
5. Denhardt, D.T., M. Noda, A.W. O'Regan, D. Pavlin, and J.S. Berman. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107:1055-1061.
6. Denhardt, D.T., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB J. 7:1475-1482.
7. Rittling, S.R., and D.T. Denhardt. 1999. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp. Nephrol. 7:103-113.
8. O'Brien, E.R., M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14:1648-1656.
9. Liaw, L., V. Lindner, S.M. Schwartz, A.F. Chambers, and C.M. Giachelli. 1995. Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ. Res. 77:665-672.
10. Liaw, L., M.P. Skinner, E.W. Raines, R. Ross, D.A. Cheresh, S.M. Schwartz, and C.M. Giachelli. 1995. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J. Clin. Invest. 95:713-724.
11. Chambers, A.F., S.M. Wilson, N. Kerkvliet, F.P. O'Malley, J.F. Harris, and A.G. Casson. 1996. Osteopontin expression in lung cancer. Lung Cancer. 15:311-323.
12. Scott, L.M., G.V. Priestley, and T. Papayannopoulou. 2003. Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing. Mol. Cell. Biol. 23:9349-9360.
13. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 90:2217-2233.
14. McKee, M.D., M.C. Farach-Carson, W.T. Butler, P.V. Hauschka, and A. Nanci. 1993. Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteins in rat bone. J. Bone Miner. Res. 8:485-496.
15. Rittling, S.R., H.N. Matsumoto, M.D. McKee, A. Nanci, X.R. An, K.E. Novick, A.J. Kowalski, M. Noda, and D.T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13:1101-1111.
16. O'Regan, A.W., G.L. Chupp, J.A. Lowry, M. Goetschkes, N. Mulligan, and J.S. Berman. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 162:1024-1031.
17. Ashkar, S., G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, S. Zawaideh, S.R. Rittling, D.T. Denhardt, M.J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 287:860-864.
18. Liaw, L., D.E. Birk, C.B. Ballas, J.S. Whitsitt, J.M. Davidson, and B.L. Hogan. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101:1468-1478.
19. Chabas, D., S.E. Baranzini, D. Mitchell, C.C. Bernard, S.R. Rittling, D.T. Denhardt, R.A. Sobel, C. Lock, M. Karpuj, R. Pedotti, et al. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:1731-1735.
20. Nau, G.J., L. Liaw, G.L. Chupp, J.S. Berman, B.L. Hogan, and R.A. Young. 1999. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67:4223-4230.
21. O'Regan, A.W., J.M. Hayden, and J.S. Berman. 2000. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J. Leukoc. Biol. 68:495-502.
22. Lin, Y.H., C.J. Huang, J.R. Chao, S.T. Chen, S.F. Lee, J.J. Yen, and H.F. Yang-Yen. 2000. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol. Cell. Biol. 20:2734-2742.
23. Calvi, L.M., N.A. Sims, J.L. Hunzelman, M.C. Knight, A. Giovannetti, J.M. Saxton, H.M. Kronenberg, R. Baron, and E. Schipani. 2001. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Invest. 107:277-286.
24. Uchida, N., A. Tsukamoto, D. He, A.M. Friera, R. Scollay, and I.L. Weissman. 1998. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest. 101:961-966.
25. Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 273:242-245.
26. Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science. 241:58-62. (published erratum appears in Science. 1989. 244:1030)
27. Stier, S., T. Cheng, D. Dombkowski, N. Carlesso, and D.T. Scadden. 2002. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 99:2369-2378.
28. Varnum-Finney, B., L. Xu, C. Brashem-Stein, C. Nourigat, D. Flowers, S. Bakkour, W.S. Pear, and I.D. Bernstein. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive notch1 signaling. Nat. Med. 6:1278-1281.
29. + cells. Blood. 103:4496-4502.
30. Arai, F., A. Hirao, M. Ohmura, H. Sato, S. Matsuoka, K. Takubo, K. Ito, G.Y. Koh, and T. Suda. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 118:149-161.
31. Carlson, K., B. Simonsson, and S. Ljunghall. 1994. Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif. Tissue Int. 55:408-411.
32. Bayless, K.J., G.A. Meininger, J.M. Scholtz, and G.E. Davis. 1998. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci. 111:1165-1174.
33. Denda, S., L.F. Reichardt, and U. Muller. 1998. Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol. Biol. Cell. 9:1425-1435.
34. Smith, L.L., and C.M. Giachelli. 1998. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. Exp. Cell Res. 242:351-360.
35. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:509-512.
36. Dimitroff, C.J., J.Y. Lee, S. Rafii, R.C. Fuhlbrigge, and R. Sackstein. 2001. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 153:1277-1286.
37. Antica, M., L. Wu, K. Shortman, and R. Scollay. 1994. Thymic stem cells in mouse bone marrow. Blood. 84:111-117.
38. Cheng, T., N. Rodrigues, H. Shen, Y. Yang, D. Dombkowski, M. Sykes, and D.T. Scadden. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 287:1804-1808.
39. Yuan, Y., H. Shen, D.S. Franklin, D.T. Scadden, and T. Cheng. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6:436-442.
40. Sauvageau, G., U. Thorsteinsdottir, C.J. Eaves, H.J. Lawrence, C. Largman, P.M. Lansdorp, and R.K. Humphries. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1753-1765.
41. Lessard, J., and G. Sauvageau. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:255-260.
42. Jang, M.S., H. Miao, N. Carlesso, L. Shelly, A. Zlobin, N. Darack, J.Z. Qin, B.J. Nickoloff, and L. Miele. 2004. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. J. Cell. Physiol. 199:418-433.
43. Sato, A., A. Iwama, N. Takakura, H. Nishio, G.D. Yancopoulos, and T. Suda. 1998. Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. Int. Immunol. 10:1217-1227.
44. Takakura, N., X.L. Huang, T. Naruse, I. Hamaguchi, D.J. Dumont, G.D. Yancopoulos, and T. Suda. 1998. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 9:677-686.
45. Garcion, E., A. Halilagic, A. Faissner, and C. Ffrench-Constant. 2004. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development. 131:3423-3432.
46. Ploemacher, R.E., J.P. van der Sluijs, C.A. van Beurden, M.R. Baert, and P.L. Chan. 1991. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood. 78:2527-2533.
47. kip1. Nat. Med. 6:1235-1240.
48. Fisher, R.C., J.D. Lovelock, and E.W. Scott. 1999. A critical role for PU.1 in homing and long-term engraftment by hematopoietic stem cells in the bone marrow. Blood. 94:1283-1290.
49. Harrison, D.E. 1980. Competitive repopulation: a new assay for longterm stem cell functional capacity. Blood. 55:77-81.
50. Stier, S., G. Totzke, E. Grunewald, T. Neuhaus, S. Fronhoffs, A. Sachinidis, H. Vetter, K. Schulze-Osthoff, and Y. Ko. 2000. Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization. FEBS Lett. 467:299-304.